Overview
Magnus Medical developed SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy), a personalized TMS protocol that uses fMRI-guided targeting to deliver rapid antidepressant effects. Their system received FDA Breakthrough Device designation and aims to compress weeks of TMS treatment into days.
More in Brain-Computer Interfaces
Latest industry news
BlueWind Medical's Revi Extend Wins FDA Clearance, Extending Implant Life to 15 Years
2026-08-06 · Product
Neurofeedback Systems Market Eyes $2.95 Billion Valuation by 2035 as Clinical and Consumer Demand Converge
2026-08-05 · Industry
Smaller Neuromodulation Devices Are Reshaping the Competitive Landscape for TMS Providers
2026-08-04 · Industry
NIH-Backed Brain-Computer Device Restores Speech in Paralyzed Patient
2026-08-03 · Research
Company details
Category
🧠 Brain-Computer Interfaces
Location
Burlingame, USA
Funding
Series B · $50M
Website
magnusmedical.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →